These findings suggest that GEO may improve pain perception and psychological factors related to pain, such as anxiety and stress, in LSS patients by acting as a serotonin receptor agonist and by inhibiting PGE2 production and COX-2 expression. Here, PTGS2 is linked to Leigh syndrome.